Diabetes microvascular complications

A clinical update

H. Khalil

Research output: Contribution to journalReview ArticleResearchpeer-review

15 Citations (Scopus)

Abstract

Background: The purpose of this study is to summarise the empirical evidence addressing diabetes microvascular complications and management. The effects of diabetes mellitus include long-term damage, dysfunction and failure of various organs. Microvascular disease tends to occur predominantly in tissues where glucose uptake is independent of insulin activity because these tissues are exposed to glucose levels that correlate very closely with blood glucose levels. These metabolic injuries cause altered blood flow and changes in endothelial permeability, extravascular protein deposition and coagulation resulting in organ dysfunction which in turn lead to microvascular complications. Method: A systematic search of the literature from 2000 to 2016 was conducted using four databases (Medline, Pubmed, Cochrane central and Google scholar) using search terms such as diabetic microvascular complications', pathogenesis, screening, risk factors, pharmacological and non-pharmacological interventions and management. Results: The current evidence supports a direct relationship between blood pressure (BP) and glycaemic control and progression of nephropathy and retinopathy. These are now considered as independent risk factors for microvascular disease progression. New fields of research addressing new drugs as potential therapeutic targets of the future will be presented. Conclusion: The prevention of microvascular disease involves paying attention to aggravating risk factors and implementing screening programmes to improve early detection.

Original languageEnglish
Pages (from-to)S133-S139
Number of pages7
JournalDiabetes and Metabolic Syndrome: Clinical Research and Reviews
Volume11
Issue numberSupp. 1
DOIs
Publication statusPublished - Nov 2017

Keywords

  • Management
  • Nephropathy
  • Neuropathy
  • Pathogenesis
  • Retinopathy

Cite this

@article{de21413ac18d4d1b8a63ac938dca6fb7,
title = "Diabetes microvascular complications: A clinical update",
abstract = "Background: The purpose of this study is to summarise the empirical evidence addressing diabetes microvascular complications and management. The effects of diabetes mellitus include long-term damage, dysfunction and failure of various organs. Microvascular disease tends to occur predominantly in tissues where glucose uptake is independent of insulin activity because these tissues are exposed to glucose levels that correlate very closely with blood glucose levels. These metabolic injuries cause altered blood flow and changes in endothelial permeability, extravascular protein deposition and coagulation resulting in organ dysfunction which in turn lead to microvascular complications. Method: A systematic search of the literature from 2000 to 2016 was conducted using four databases (Medline, Pubmed, Cochrane central and Google scholar) using search terms such as diabetic microvascular complications', pathogenesis, screening, risk factors, pharmacological and non-pharmacological interventions and management. Results: The current evidence supports a direct relationship between blood pressure (BP) and glycaemic control and progression of nephropathy and retinopathy. These are now considered as independent risk factors for microvascular disease progression. New fields of research addressing new drugs as potential therapeutic targets of the future will be presented. Conclusion: The prevention of microvascular disease involves paying attention to aggravating risk factors and implementing screening programmes to improve early detection.",
keywords = "Management, Nephropathy, Neuropathy, Pathogenesis, Retinopathy",
author = "H. Khalil",
year = "2017",
month = "11",
doi = "10.1016/j.dsx.2016.12.022",
language = "English",
volume = "11",
pages = "S133--S139",
journal = "Diabetes and Metabolic Syndrome: Clinical Research and Reviews",
issn = "1871-4021",
publisher = "Elsevier",
number = "Supp. 1",

}

Diabetes microvascular complications : A clinical update. / Khalil, H. .

In: Diabetes and Metabolic Syndrome: Clinical Research and Reviews, Vol. 11, No. Supp. 1, 11.2017, p. S133-S139.

Research output: Contribution to journalReview ArticleResearchpeer-review

TY - JOUR

T1 - Diabetes microvascular complications

T2 - A clinical update

AU - Khalil, H.

PY - 2017/11

Y1 - 2017/11

N2 - Background: The purpose of this study is to summarise the empirical evidence addressing diabetes microvascular complications and management. The effects of diabetes mellitus include long-term damage, dysfunction and failure of various organs. Microvascular disease tends to occur predominantly in tissues where glucose uptake is independent of insulin activity because these tissues are exposed to glucose levels that correlate very closely with blood glucose levels. These metabolic injuries cause altered blood flow and changes in endothelial permeability, extravascular protein deposition and coagulation resulting in organ dysfunction which in turn lead to microvascular complications. Method: A systematic search of the literature from 2000 to 2016 was conducted using four databases (Medline, Pubmed, Cochrane central and Google scholar) using search terms such as diabetic microvascular complications', pathogenesis, screening, risk factors, pharmacological and non-pharmacological interventions and management. Results: The current evidence supports a direct relationship between blood pressure (BP) and glycaemic control and progression of nephropathy and retinopathy. These are now considered as independent risk factors for microvascular disease progression. New fields of research addressing new drugs as potential therapeutic targets of the future will be presented. Conclusion: The prevention of microvascular disease involves paying attention to aggravating risk factors and implementing screening programmes to improve early detection.

AB - Background: The purpose of this study is to summarise the empirical evidence addressing diabetes microvascular complications and management. The effects of diabetes mellitus include long-term damage, dysfunction and failure of various organs. Microvascular disease tends to occur predominantly in tissues where glucose uptake is independent of insulin activity because these tissues are exposed to glucose levels that correlate very closely with blood glucose levels. These metabolic injuries cause altered blood flow and changes in endothelial permeability, extravascular protein deposition and coagulation resulting in organ dysfunction which in turn lead to microvascular complications. Method: A systematic search of the literature from 2000 to 2016 was conducted using four databases (Medline, Pubmed, Cochrane central and Google scholar) using search terms such as diabetic microvascular complications', pathogenesis, screening, risk factors, pharmacological and non-pharmacological interventions and management. Results: The current evidence supports a direct relationship between blood pressure (BP) and glycaemic control and progression of nephropathy and retinopathy. These are now considered as independent risk factors for microvascular disease progression. New fields of research addressing new drugs as potential therapeutic targets of the future will be presented. Conclusion: The prevention of microvascular disease involves paying attention to aggravating risk factors and implementing screening programmes to improve early detection.

KW - Management

KW - Nephropathy

KW - Neuropathy

KW - Pathogenesis

KW - Retinopathy

UR - http://www.scopus.com/inward/record.url?scp=85007564449&partnerID=8YFLogxK

U2 - 10.1016/j.dsx.2016.12.022

DO - 10.1016/j.dsx.2016.12.022

M3 - Review Article

VL - 11

SP - S133-S139

JO - Diabetes and Metabolic Syndrome: Clinical Research and Reviews

JF - Diabetes and Metabolic Syndrome: Clinical Research and Reviews

SN - 1871-4021

IS - Supp. 1

ER -